'Not just Methadone Tracy': Transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings

Addiction

Volumn 109, Issue 3, 2014, Pages 452-459

  Rance, Jake ^a   Treloar, Carla ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; Hepatitis C treatment; Integrated care; Opiate substitution therapy; Qualitative research; Treatment identities

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; AUSTRALIA; COMPLICATION; FEMALE; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HEPATITIS C, CHRONIC; HUMAN; HUMAN RELATION; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PROCEDURES; QUALITATIVE RESEARCH; SELF CONCEPT;

ADULT; AMBULATORY CARE FACILITIES; ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; DELIVERY OF HEALTH CARE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; METHADONE; MIDDLE AGED; NEW SOUTH WALES; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROFESSIONAL-PATIENT RELATIONS; QUALITATIVE RESEARCH; SELF CONCEPT;

EID: 84893856590     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12392     Document Type: Article

References (26)

1. Bruggmann P. Accessing hepatitis C patients who are difficult to reach: it is time to overcome barriers. J Viral Hepat 2012; 19: 829-835.
2. Grebely J., Tyndall M. J. Management of HCV and HIV infections among people who inject drugs. Curr Opin HIV AIDS 2011; 6: 501-507.
3. Hellard M., Sacks-Davis R., Gold J. Hepatitis C treatment for injection drug users: a review of the available evidence. Clin Infect Dis 2009; 49: 561-573.
4. Day C., Haber P. S. Managing drug dependence in people with hepatitis C. In: Dore G., Jauncey M., editors. Hepatitis C Clinical Managment in Opiate Pharmacotherapy Settings. Sydney: Australasian Society for HIV Medicine; 2009, pp. 35-42.
5. Dore G., Jauncey M. An overview of hepatitis C clinical managment in opiate pharmacotherapy settings. In: Dore G., Jauncey M., editors. Hepatitis C Clinical Managment in Opiate Pharmacotherapy Settings. Sydney: Australasian Society for HIV Medicine; 2009, pp. 7-14.
6. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2012. Sydney: The Kirby Institute, The University of New South Wales, NSW 2052; 2012.
7. Marsch L. A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998; 93: 515-532.
8. Ward J., Mattick R., Hall W. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam: Harwood Academic Publishers; 1998.
9. Fraser S. The chronotope of the queue: methadone maintenance treatment and the production of time, space and subjects. Int J Drug Policy 2006; 17: 192-202.
10. Radcliffe P., Stevens A. Are drug treatment services only for 'thieving junkie scumbags'? Drug users and the management of stigmatised identities. Soc Sci Med 2008; 67: 1065-1073.
11. Smith C. B. R. Socio-spatial stigmatization and the contested space of addiction treatment: remapping strategies of opposition to the disorder of drugs. Soc Sci Med 2010; 70: 859-866.
12. Smith C. B. R. A users' guide to 'Juice Bars' and 'Liquid Handcuffs': fluid negotiations of subjectivity, space and the substance of methadone treatment. Space Cult 2011; 14: 291-309.
13. Rance J., Newland J., Hopwood M., Treloar C. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics. Soc Sci Med 2012; 74: 245-253.
14. Fraser S., Valentine K. Substance and Substitution: Methadone Subjects in Liberal Societies. Basingstoke: Palgrave Macmillan; 2008.
15. Harris J., McElrath K. Methadone as social control: institutionalized stigma and the prospect of recovery. Qual Health Res 2012; 22: 810-824.
16. McIntosh J., McKeganey N. Addicts' narratives of recovery from drug use: constructing a non-addict identity. Soc Sci Med 2000; 50: 1501-1510.
17. Winslade J. Utilising discursive positioning in counselling. Br J Guid Counc 2005; 33: 351-364.
18. Alavi M., Grebely J., Micallef M., Dunlop A., Balcomb A., Day C. etal. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: the ETHOS study. Clin Infect Dis 2013; 57: S62-69.
19. Crawford S., Bath N. Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection. Clin Infect Dis 2013; 57: S75-79.
20. Glaser B., Strauss A. Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine de Gruyter; 1967.
21. Patton M. Qualitative Research and Evaluation Methods. Thousand Oaks, CA: Sage; 2002.
22. Bourgois P. Disciplining addictions: the bio-politics of methadone and heroin in the United States. Cult Med Psychiatry 2000; 24: 165-195.
23. Simeons S., Matheson C., Bond C., Inkster K., Ludbrook A. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. Br J Gen Pract 2005; 55: 139-146.
24. Lilly R., Quirk A., Rhodes T., Stimson G. V. Sociality in methadone treatment: understanding methadone treatment and service delivery as a social process. Drugs: Educ Prev Policy 2000; 7: 163-178.
25. Mol A. The Logic of Care: Health and the Problem of Patient Choice. London: Routledge; 2008.
26. Fox N. Postmodern perspectives on care: the vigil and the gift. Crit Soc Policy 1995; 15: 107-125.